By Tony Fong

SAN FRANCISCO (GenomeWeb News) – Dutch molecular diagnostics firm Agendia plans on going public some time this year, a company official said.

At the JP Morgan Healthcare Conference in San Francisco this week, Bernhard Sixt, Agendia's president and CEO, told GenomeWeb Daily News that the company is planning an initial public offering this year, though a specific timeline and exchange has not yet been decided.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.